C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media

More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)

Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
12/2004
12/02/2004	WO2004104161A2 Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same
12/02/2004	WO2004103271A2 Disease prevention and vaccination prior to thymic reactivations
12/02/2004	WO2004090095A3 Generation of human regulatory t cells by bacterial toxins for the treatment of inflammatory disorders
12/02/2004	WO2004087868A3 Dna polymerase fusions and uses thereof
12/02/2004	WO2004081174A3 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker
12/02/2004	WO2004078909A8 Identification of antigen epitopes
12/02/2004	WO2004044128A3 An associative analysis of gene expression array data
12/02/2004	WO2004009765A3 Strategies for gene expression analysis
12/02/2004	WO2003100013A3 NON-REVERTIBLE β-OXIDATION BLOCKED CANDIDA TROPICALIS
12/02/2004	WO2003072709A3 Variant tat proteins and methods for use thereof
12/02/2004	US20040242526 Disruption of the REG pathway
12/02/2004	US20040242502 Semi-synthetic saponin analogs with carrier and immune stimulatory activities for DNA and RNA vaccines
12/02/2004	US20040242484 Specific polypeptides, useful as nematocides
12/02/2004	US20040241786 Single tube screen
12/02/2004	US20040241732 Method of generating long nucleic acid molecules of defined sequence
12/02/2004	US20040241730 Visualizing expression data on chromosomal graphic schemes
12/02/2004	US20040241722 Molecular haplotyping of genomic DNA
12/02/2004	US20040241716 Terminal-phosphate-labeled nucleotides with new linkers
12/02/2004	US20040241187 An inactivated, disrupted influenza virus preparation of a hemagglutinin antigen stabilised by alpha-tocopherol succinate in the absence of thiomersal or at low levels of thiomersal; hemagglutinin detectable by a single radial immunoassay (SRID); mercury-free preservative; administering by any route
12/02/2004	US20040241158 Targetting antibodies containing haptens, cleaning agent, and drug delivery agent; tissue-directed therapy; solid phase synthesis
12/02/2004	CA2566749A1 Efficient haploid cell sorting for flow cytometer systems
12/02/2004	CA2528521A1 Disease prevention and vaccination prior to thymic reactivations
12/02/2004	CA2526985A1 Method for isolating and cloning high molecular weight polynucleotide molecules from the environment
12/02/2004	CA2526440A1 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
12/02/2004	CA2526409A1 Nucleic acid processing methods, kits and devices
12/02/2004	CA2524950A1 Methods for facilitating recovery of functions of endogenous or implanted or transplanted stem cells using high molecular weight hyaluronic acid
12/02/2004	CA2524130A1 Ranbp2 as modifier of the pten/igf pathway and methods of use
12/02/2004	CA2523786A1 A .delta.-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts
12/01/2004	EP1482053A2 Eukaryotic host cell line in which an endogenous gene has been activated, and uses thereof
12/01/2004	EP1482046A2 G-CSF analog compositions and methods
12/01/2004	EP1482045A2 G-CSF analog compositions and methods
12/01/2004	EP1481992A2 Humanized antibodies that sequester amyloid beta peptide
12/01/2004	EP1481989A1 A-33 related antigens and their pharmacological uses
12/01/2004	EP1481091A2 Multivariate random search method with multiple starts and early stop for identification of differentially expressed genes based on microarray data
12/01/2004	EP1257584B9 Humanized antibodies that sequester amyloid beta peptide
12/01/2004	EP1088060A4 Enzyme stabilization by cationic surfactants
12/01/2004	CN1551728A Production of transduced hematopoietic progenitor cells
12/01/2004	CN1550547A Embryogenic culture initiation of douglas-fir by maltose
11/2004
11/30/2004	US6825340 Mixing composition with reducing agent, heating; wherein any ribonucleases in composition are substantially inactivated or inhibited
11/25/2004	WO2004101769A2 Proteins, sensors, and methods of characterizing analytes using the same
11/25/2004	WO2004101767A2 Cbi analogues of the duocarmycins and cc-1065
11/25/2004	WO2004101766A2 Grp94-based compositions and methods of use thereof
11/25/2004	WO2004101765A2 Methods and apparatus for adeno associated virus purification
11/25/2004	WO2004101764A2 Methods of modulating metastasis and skeletal related events resulting from metastases
11/25/2004	WO2004101762A2 Detection and treatment of cancers of the colon
11/25/2004	WO2004101761A2 METHODS FOR THE IDENTIFICATION OF INHIBITORS OF CAX1-LIKE Ca+2/H+ANTIPORTER ACTIVITY IN PLANTS
11/25/2004	WO2004101757A2 Production of polyunsaturated fatty acids in oleaginous yeasts
11/25/2004	WO2004101753A2 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
11/25/2004	WO2004101752A2 Compounds for treatment of inflammation, diabetes and related disorders
11/25/2004	WO2004101751A2 A modified rubisco large subunit ∈n-methyltransferase useful for targeting molecules to the active-site vicinity of ribulose-1, 5-bisphosphate
11/25/2004	WO2004101750A2 IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
11/25/2004	WO2004101749A2 Methods for amplification of nucleic acid sequences using staggered ligation
11/25/2004	WO2004101747A2 Identification and use of gpr54 and its ligands for reproductive disorders and contraception
11/25/2004	WO2004101746A2 Production of carotenoids in microorganisms
11/25/2004	WO2004101745A2 NOVEL REGULATORY MECHANISMS OF NF-kappaB
11/25/2004	WO2004101743A2 Three dimensional cell cultures in a microscale fluid handling system
11/25/2004	WO2004101742A2 Protease inhibitors for coronaviruses and sars-cov and the use thereof
11/25/2004	WO2004101740A2 Clotting factor-fc chimeric proteins to treat hemophilia
11/25/2004	WO2004101739A2 Methods for chemically synthesizing immunoglobulin chimeric proteins
11/25/2004	WO2004101738A2 Domain-exchanged binding molecules, methods of use and methods of production
11/25/2004	WO2004101737A2 A novel adjuvant capable of specifically activating the adaptive immune response
11/25/2004	WO2004085611A3 Model for mutually exclusive domain folding molecular switch
11/25/2004	WO2004081195A3 Use of secretin and secretin analogs to treat affective disorders
11/25/2004	WO2004081178A3 Methods and composition for producing infectious hpv stocks
11/25/2004	WO2004074428A3 Treatment of metabolic disorders
11/25/2004	WO2004072255A3 Methods of treating disease
11/25/2004	WO2004072247A3 Polymerase-based protocols for generating chimeric and combinatorial chimeric oligonucleotides
11/25/2004	WO2004063346A3 Lysozyme transgenic ungulates
11/25/2004	WO2003000849A3 Methods for representing sequence-dependent contextual information present in polymer sequences and uses thereof
11/25/2004	US20040237130 Propagating conifer somatic embryos; preparing nutrient broth comprising combinations of glucose and maltose, inoculate with conifer explants recover embryonic suspensor masses; tissue engineering
11/25/2004	US20040235029 In vitro translation system
11/25/2004	US20040235027 Preparation and application of ligand-biopolymer conjugates
11/25/2004	US20040235020 Methods for monitoring drug activities in vivo
11/25/2004	US20040234957 Compositions and methods for labeling oligonucleotides
11/25/2004	US20040234950 Method for virus propagation
11/25/2004	US20040234649 Grinding starch-containing plant material comprising corn, sorghum, millet, wheat, barley, rye, or mixtures thereof, saccharifying starch without cooking, fermenting incubated starch and recovering ethanol from fermentation; producing high alcohol beer and high protein distiller's dried grain
11/25/2004	US20040231909 Motorized vehicle having forward and backward differential structure
11/25/2004	US20040231060 Efficient, economical production of free sugars and oligosaccharides from plant material; mild chemical pretreatment; reduced toxicity
11/25/2004	CA2526935A1 Production of polyunsaturated fatty acids in oleaginous yeasts
11/25/2004	CA2525929A1 Methods of modulating metastasis and skeletal related events resulting from metastases
11/25/2004	CA2525385A1 Grp94-based compositions and methods of use thereof
11/25/2004	CA2525370A1 Domain-exchanged binding molecules, methods of use and methods of production
11/25/2004	CA2524882A1 Protease inhibitors for coronaviruses and sars-cov and the use thereof
11/25/2004	CA2524780A1 Compounds for treatment of inflammation, diabetes and related disorders
11/25/2004	CA2524496A1 Three dimensional cell cultures in a microscale fluid handling system
11/25/2004	CA2524095A1 Proteins, sensors, and methods of characterizing analytes using the same
11/25/2004	CA2522692A1 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
11/24/2004	EP1478783A2 Compositions and methods for rolling circle amplification
11/24/2004	EP1478774A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
11/24/2004	EP1478656A2 Oligonucleotide compositions with enhanced efficiency
11/24/2004	EP1200605B1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/18/2004	WO2004099390A2 Molecules for disease detection and treatment
11/18/2004	WO2004099388A2 Cbl-b polypeptides, complexes and related methods
11/18/2004	WO2004099385A2 Telomere elongation
11/18/2004	WO2004099384A2 Solid phase cell lysis and capture platform
11/18/2004	WO2004099383A2 Chromatographic assay system
11/18/2004	WO2004099381A2 Genetically modified yeast species and fermentation processes using genetically modified yeast
11/18/2004	WO2004099379A2 Use of jag2 expression in diagnosis of plasma cell disorders
11/18/2004	WO2004099378A2 Automated laboratory for high-throughput biological assays and rna interference
11/18/2004	WO2004099377A2 An autologous upregulation mechanism allowing optimized cell type-specific and regulated gene expression cells

1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 100